One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
Leveraging a variety of artificial intelligence (AI) capabilities, the newly launched Voluson Signature 20 and 18 ultrasound devices may significantly enhance efficiency of common ultrasound exams for women.
GE HealthCare, the manufacturer of the Voluson Signature 20 and 18 ultrasound devices, said key efficiencies include:
• a 48 percent time reduction for performing fetal heart assessments due to a fetalHS feature, which provide stepwise AI guidance to identify normal fetal heart anatomy;
• a 40 percent time reduction for performing second trimester exams as per standards from the International Society of Ultrasound in Obstretics and Gynecology (ISUOG) due to the SonoLyst feature, a suite of automated AI tools; and
• a 76 percent keystroke reduction with the automated plane alignment and measurements of the SonoPelvicFloor feature.
"We've seen huge advancements in ultrasound technology, including the use of AI, resulting in a new era of ultrasound scanning. The new Voluson Signature series features innovative tools clinicians can rely on, and the automated functions help reduce work stress and improve workflows," noted Ben Csapo, M.D., a maternal fetal medicine specialist in Graz, Austria.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.